Days
At A Glance
Speakers
Session Type
Search
Sat 03 May 2008
S
Sun 04 May 2008
S
Mon 05 May 2008
M
Tue 06 May 2008
T
Wed 07 May 2008
W
All
Type
Workshop
Oral
Expert
Plenary
Catering and Social
Nurse
Other
Symposium
Not specified
Hide all
Show all
Saturday 03 May
4 sessions
12:00 - 20:00
Registration
17:30 - 19:30
Opening Ceremony: Geoffrey Harris Prize Lecture
HALL 1
Chair: E. Nieschlag (Germany), President ESE
GH1
Opening Ceremony: Geoffrey Harris Prize Lecture
From Geoffrey Harris' hypothalamic principle to a unified theory of stress and stress system disorders
G. Chrousos
17:30 - 19:30
Opening Ceremony: European Journal of Endocrinology Prize Lecture
HALL 1
Chair: C. Strasburger (Germany), Editor EJE
EJE1
Opening Ceremony: European Journal of Endocrinology Prize Lecture
Sex Steroids in the Regulation of Bone Metabolism in Men
C. Ohlsson
19:30 - 22:00
Welcome Reception
EXHIBITION
Sunday 04 May
25 sessions
08:30 - 10:00
Symposium 1 - Clinical: The trick is the combination
HALL 1
Chairs: A. van der Lely (Netherlands) & V. Pirags (Lithuania)
S1.1
Symposium 1 - Clinical: The trick is the combination
Treatment of hyperthyroidism: block and replace versus titration
L. Bartalena
S1.2
Symposium 1 - Clinical: The trick is the combination
The combination of GH/IGF-I makes the difference!
J. Janssen
S1.3
Symposium 1 - Clinical: The trick is the combination
Medical Treatment of Acromegaly: Dual Blockade with a Somatostatin Analog and Pegvisomant
J. Jorgensen
S1.4
Symposium 1 - Clinical: The trick is the combination
The combined Androgen and Estrogen replacement therapy in women
W. Arlt
08:30 - 10:00
Symposium 2 - Basic: The TGF-beta Superfamily
HALL 7
Chairs: C.V. Alvarez (Spain) & D. Salvatore (Italy)
S2.1
Symposium 2 - Basic: The TGF-beta Superfamily
BMP to the Bone
P. Dijke
S2.2
Symposium 2 - Basic: The TGF-beta Superfamily
Integration of Skeletal Regulatory Signals in Nuclear Microenvironments
G. Stein
S2.3
Symposium 2 - Basic: The TGF-beta Superfamily
TGF-beta family ligands in glucose and fat homeostasis in adults
A. Schneyer
S2.4
Symposium 2 - Basic: The TGF-beta Superfamily
The Dependence Receptor notion: When apoptosis regulates tumor progression and metastasis
P. Mehlen
08:30 - 10:00
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
HALL 3
Chairs: M. Knip (Finland) & G. Krassas (Greece)
S3.1
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Why is the incidence of autoimmune diseases increasing in the modern world?
J. Bach
S3.2
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Genome-wide association studies and hormone-dependent cancers
D. Hunter
S3.3
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Gene Environment Interactions in Type 1 Diabetes
G.S. Eisenbarth
S3.4
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Gene-environment interactions in thyroid autoimmunity.
L. Hegedüs
10:05 - 10:50
Plenary Lecture 1
Supported by Bayer-Schering Pharma
HALL 1
Chairs: S. Lamberts (Netherlands) & F. Casanueva (Spain)
PL1
Plenary Lecture 1
Estrogens and cardiovascular disease
M. Mendelssohn
10:50 - 11:15
Coffee Break & Exhibition
11:15 - 12:45
Symposium 4 - Clinical: Is there a crisis of male reproduction?
HALL 1
Chairs: A. Milewicz (Poland) & M. Simoni (Italy)
S4.1
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Deterioration of male reproductive function in Europe. Geographical differences
N. Joergensen
S4.2
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Life style factors and chemical exposures impair male reproductive development and function in humans
K. Main
S4.3
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Metabolic syndrome in Klinefelter syndrome (47,XXY)
A. Bojesen
S4.4
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Metabolic Aspects of Testosterone Replacement
M. Zitzmann
11:15 - 12:45
Symposium 5 - Basic: Protein modifications / Proteomics
HALL 7
Chairs: S.B. Bravo (Spain) & A.Vidal (Spain)
S5.1
Symposium 5 - Basic: Protein modifications / Proteomics
Comparative proteomics as a tool in biology: The protein microscope
T. Nilsson
S5.2
Symposium 5 - Basic: Protein modifications / Proteomics
Applying proteomics to thyroid tumour diagnosis
D. Führer
S5.3
Symposium 5 - Basic: Protein modifications / Proteomics
Targeting ubiquitin networks
I. Dikic
S5.4
Symposium 5 - Basic: Protein modifications / Proteomics
Progesterone Receptor Responses Modified by SUMO in the Endometrium
J. Brosens
11:15 - 12:45
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
HALL 3
Chairs: K. Raile (Germany) & G. Bolli (Italy)
S6.1
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Embryonic Pancreatic Development
F. Spagnoli
S6.2
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
The zinc-finger factor Insm1 (IA-1) is essential for the development of endocrine cells of the pancreas, intestine and adrenal gland.
C. Birchmeier
S6.3
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Hyperinsulinism in humans
K. Hussain
S6.4
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Carboxylester lipase (CEL) VNTR links exocrine dysfunction to endocrine dysfunction
P. Njolstad
11:15 - 12:45
Oral Communication 1: Neuroendocrinology & Pituitary
HALL 4/5
Chairs: S. Tsagarakis (Greece) & A. Giustina (Italy)
OC1.1
Oral Communication 1: Neuroendocrinology & Pituitary
Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage in 921 patients – the German Interdisciplinary Database
OC1.2
Oral Communication 1: Neuroendocrinology & Pituitary
The adequacy of thyroxine replacement in hypopituitary patients
OC1.3
Oral Communication 1: Neuroendocrinology & Pituitary
Limited effects of Growth Hormone Replacement in Adultswith Growth Hormone Deficiency after Treatment for Acromegaly
OC1.4
Oral Communication 1: Neuroendocrinology & Pituitary
Pasireotide (SOM230) effectively reduces pituitary tumor volume in patients with active acromegaly: preliminary 6-month results from a Phase II extension study
OC1.5
Oral Communication 1: Neuroendocrinology & Pituitary
CARDIAC PERFORMANCE AFTER LONG-TERM TREATMENT WITH PEGVISOMANT IN PATIENTS WITH ACROMEGALIC : A RADIONUCLIDE ANGIOGRAPHY STUDY.
OC1.6
Oral Communication 1: Neuroendocrinology & Pituitary
The metabolic effects of ghrelin and glucocorticoids are mediated by AMP-activated protein kinase (AMPK) and endogenous cannabinoids
OC1.7
Oral Communication 1: Neuroendocrinology & Pituitary
INTERMITTENT HIGH GLUCOSE CONCENTRATIONS REDUCE NEURONAL PRECURSOR PROLIFERATION BY ALTERING THE IGF SYSTEM: THE INVOLVEMENT OF THE NEUROPROTECTIVE FACTOR SELADIN-1.
OC1.8
Oral Communication 1: Neuroendocrinology & Pituitary
Differential sensitivity of men and women to anorexigenic and memory improving effects of intranasal insulin
OC1.9
Oral Communication 1: Neuroendocrinology & Pituitary
Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men
13:00 - 14:30
Satellite Symposium: Lilly - New treatment approaches for type 2 diabetes mellitus that target pathophysiology
HALL 3
13:00 - 14:30
Satellite Symposium: Ipsen - Pathogenesis & management of aggressive pituitary tumours
HALL 1
13:00 - 15:00
Lunch
13:00 - 15:00
Poster session
14:30 - 15:30
Meet the Expert 1: The impact of abdominal obesity
HALL 1
ME1
Meet the Expert 1: The impact of abdominal obesity
The impact of abdominal obesity
D. Micic
14:30 - 15:30
Meet the Expert 2: The necessity of Insulin analogues
HALL 7
ME2
Meet the Expert 2: The necessity of Insulin analogues
Rational for using insulin analogues in the treatment of diabetes mellitus
G.B. Bolli
14:30 - 15:30
Meet the Expert 3: Contraception in the new millennium
HALL 3
ME3
Meet the Expert 3: Contraception in the new millennium
Contraception in the New Millennium
G. Mastorakos
14:30 - 15:30
Meet the Expert 4: A living method: In vivo microscopy
HALL 4/5
ME4
Meet the Expert 4: A living method: In vivo microscopy
Two-photon microscopy of cancer invasion and metastasis
P. Friedl
15:30 - 17:00
Symposium 7 - Translational: The functions of peripheral GHrelin
HALL 1
Chairs: C. Dieguez (Spain) & M. Korbonits (United Kingdom)
S7.1
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and the Gonads
M. Tena-Sempere
S7.2
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and the endocrine pancreas
R. Granata
S7.3
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and Bone
P.J. Delhanty
S7.4
Symposium 7 - Translational: The functions of peripheral GHrelin
Peptidyl growth hormone secretagogues in cardioprotection
H. Ong
15:30 - 17:00
Symposium 8 - Basic: Nuclear Receptors
HALL 7
Chairs: A. Aranda (Spain) & G. Vollmer (Germany)
S8.1
Symposium 8 - Basic: Nuclear Receptors
LXR
E. Saez
S8.2
Symposium 8 - Basic: Nuclear Receptors
Kinase signaling and retinoic acid nuclear receptors
C. Rochette-Egly
S8.3
Symposium 8 - Basic: Nuclear Receptors
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
R. Schüle
S8.4
Symposium 8 - Basic: Nuclear Receptors
Estrogen-related receptors as regulators of energy homeostasis and adaptive metabolism
A. Kralli
15:30 - 17:00
Symposium 9 - Clinical: New aspects of adrenal disease
HALL 3
Chairs: B. Allolio (Germany) & J. Bertherat (France)
S9.1
Symposium 9 - Clinical: New aspects of adrenal disease
The role of toll-like receptors
K. Zacharowski
S9.2
Symposium 9 - Clinical: New aspects of adrenal disease
The expanding spectrum of DAX1 and SF1 mutations
J. Achermann
S9.3
Symposium 9 - Clinical: New aspects of adrenal disease
REPLACEMENT AND QoL IN PATIENTS WITH ADRENAL INSUFFICIENCY
G. Johansson
S9.4
Symposium 9 - Clinical: New aspects of adrenal disease
Genetics of chromaffin tumours
A-P. Gimenez-Roqueplo
15:30 - 17:00
Oral Communication 2: Thyroid
HALL 4/5
Chairs: R. Elisei (Italy) & B. Jarzab (Poland)
OC2.1
Oral Communication 2: Thyroid
Analysis of early gene expression in mouse thyroid development
OC2.2
Oral Communication 2: Thyroid
Identification of 25 novel NKX2-1 gene mutations in 100 patients with broad spectrum of brain and thyroid dysfunctions
OC2.3
Oral Communication 2: Thyroid
Global Proteomic analysis in human thyroid proliferative/neoplastic primary culture lines
OC2.4
Oral Communication 2: Thyroid
Identification and enrichment of thyroid stem cells in anaplastic cell lines.
OC2.5
Oral Communication 2: Thyroid
Fetal cell microchimerism in papillary thyroid cancer: A possible role in tumor damage and tissue repair
OC2.6
Oral Communication 2: Thyroid
Ga-68-Dotatoc PET detects Somatostatin receptors in normal thyroids and various thyroid pathologies
OC2.7
Oral Communication 2: Thyroid
Impact of Resistance to Thyroid Hormone on the Cardiovascular System in Adult Humans
OC2.8
Oral Communication 2: Thyroid
Graves’ ophthalmopathy in patients treated with radioiodine I-131
OC2.9
Oral Communication 2: Thyroid
Subclinical hypothyroidism in older patients: an analysis of natural course and risk factors for the thyroid failure
17:15 - 18:00
Plenary Lecture 2
HALL 1
Chairs: I. Gerendai (Hungary) & J. Wass (United Kingdom)
PL2
Plenary Lecture 2
Why did Moses live to be 120?
N.Barzilai
18:00 - 18:15
Coffee
18:15 - 19:45
Satellite Symposium: Novartis Oncology - Optimal management of acromegaly - today, tomorrow and throughout a patient's life
HALL 3
18:15 - 19:45
Satellite Symposium: Pfizer - KIMS Highlights: Does GH replacement have an impact on mortality rate in adult hypopituitary patients?
HALL 1
Monday 05 May
24 sessions
08:30 - 10:00
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
HALL 1
Chair: P. Clayton (UK)
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
CON
M. Savage
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
PRO
J.M. Wit
08:30 - 10:00
Symposium 11 - Basic: Epigenetics in endocrinology
HALL 7
Chairs: H. Krude (Germany) & L. Hofland (Netherlands)
S11.1
Symposium 11 - Basic: Epigenetics in endocrinology
Epimutations in the human genome
B. Horsthemke
S11.2
Symposium 11 - Basic: Epigenetics in endocrinology
Mechanisms of selective gene expression in development
V. Heyningen
S11.3
Symposium 11 - Basic: Epigenetics in endocrinology
Epigenetics in mammalian development
M. Zernicka-Goetz
S11.4
Symposium 11 - Basic: Epigenetics in endocrinology
Imprinting in Human Disease – Lessons from the study of Transient Neonatal Diabetes
K. Temple
08:30 - 10:00
Symposium 12 - Translational: Addicted to Food?
HALL 3
Chairs: S. Farooqi (UK) & V. Popovic (Serbia)
S12.1
Symposium 12 - Translational: Addicted to Food?
The Selfish Brain: Competition for Energy Resources
A. Peters
S12.2
Symposium 12 - Translational: Addicted to Food?
Peptide YY: Cure for obesity?
R. Batterham
S12.3
Symposium 12 - Translational: Addicted to Food?
Hypothalamic regulation of energy balance
D. Cota
S12.4
Symposium 12 - Translational: Addicted to Food?
Metabolic and reward cues affect the central clock in the brain
E.Challet
08:30 - 10:00
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
HALL 4/5
Chairs: A. Pfeiffer (Berlin) & G. Vollmer (Dresden)
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Endocrine disruptors and the thyroid
J. Kohrle
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Endocrine disruptors and reproductive hormones
H. Jarry
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Plant derived compunds with endocrine actions: Hops and Xanthohumols
B. Hofmann
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Danger of combination? Interactions of low ose hormone therapy with phytoestrogens
G. Vollmer
10:05 - 10:50
Plenary Lecture 3
HALL 1
Chairs: T. Gudermann (Germany) & R. Gaillard (Switzerland)
PL3
Plenary Lecture 3
A cofactor network that controls PGC-1alpha activity and energy homeostasis
J. Auwerx
10:50 - 11:15
Coffee Break & Exhibition
11:15 - 12:45
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
Supported by Bayer Schering Pharma
HALL 1
Chair: P. Bouchard (France)
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
CON
G. Forti
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
PRO
B. Lunenfeld
11:15 - 12:45
Symposium 14: Basic Highlights
HALL 7
Chairs: J. Castano (Spain) & J. C. Moreno (Netherlands)
S14.1
Symposium 14: Basic Highlights
Direct vizualization of cyclic AMP levels in three dimensional cultures of thyroid follicles
D. Calebiro
Germany
S14.2
Symposium 14: Basic Highlights
Dopamine receptor 2 activation reduces cells viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion
M. Zatelli
S14.3
Symposium 14: Basic Highlights
Variants of the phosphodiesterase 11A (PDE11A4) gene and genetic predisposition to adrenocortical tumors (ACT)
R. Libé
S14.4
Symposium 14: Basic Highlights
Targeted disruption of Slc2a8 (GLUT8) reduces ATP levels and mitochondrial potential of spermatozoa
V. Gawlik
S14.5
Symposium 14: Basic Highlights
KLF11 differentially regulates PDX1-induced activation of the human insulin promoter in rodent beta-cells and human non-beta-cells
N. Perakakis
S14.6
Symposium 14: Basic Highlights
Specific neuronal deletion of cannabinoid type 1 receptor (CB1) mice exhibits reduced fat mass and diet-induced obesity resistance
C. Cervino
11:15 - 12:45
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
HALL 3
Chairs: M. Ranke (Germany) & D. Micic (Serbia)
S15.1
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
SHOX Deficiency: Does GH Treatment Do any Good?
W. Blum
S15.2
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
GH therapy in Noonan Syndrome – facts and myths
J. Dahlgren
S15.3
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
GH therapy in children with Prader Willi Syndrome (PWS)
A. Hokken-Koelega
S15.4
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
Consensus on GH Treatment in SGA
P. Clayton
11:15 - 12:45
Oral Communication 3: Diabetes and Obesity
HALL 4/5
Chairs: M. Coculescu (Romania) & U. Pagotto (Italy)
OC3.1
Oral Communication 3: Diabetes and Obesity
Interaction of hypothalamic G-protein-coupled receptors (GPCRs) involved in weight regulation
OC3.2
Oral Communication 3: Diabetes and Obesity
Adiponectin inhibits AMP kinase activity and increases insulin secretion in MIN6 cells
OC3.3
Oral Communication 3: Diabetes and Obesity
Regulation of lipolysis by corticotropin releasing hormone in brown adipocytes
OC3.4
Oral Communication 3: Diabetes and Obesity
Fatty acid-induced induction of TLR-4/NFkB-pathway in adipocytes links nutritional signaling with innate immunity
OC3.5
Oral Communication 3: Diabetes and Obesity
Hormonal regulation of 11-β-HSD1 expression and activity in differentiated 3T3- L1 adipocytes
OC3.6
Oral Communication 3: Diabetes and Obesity
Transcriptional control of hepatic and systemic lipid metabolism by the nuclear receptor co-factor RIP140
OC3.7
Oral Communication 3: Diabetes and Obesity
Impact of metformin on gene expression, glucose uptake and lipolysis in adipocytes
OC3.8
Oral Communication 3: Diabetes and Obesity
Retrovirally transduced, antigen-specific T cells for therapy of type 1 diabetes
OC3.9
Oral Communication 3: Diabetes and Obesity
Effect of baseline sample characteristics, comparator drug, co-interventions and rosigitazone doses on the risk of myocardial infarction. Multivariable lineal regression analysis
13:00 - 14:30
Satellite Symposium: Pfizer - The role of pegvisomant in the current treatment of acromegaly
HALL 1
13:00 - 14:30
Lunch
13:00 - 15:30
STAND BY ME!! SESSION
All poster authors will discuss posters during lunch. Members of the Executive & Program Committees will be active participants.
EXHIBITION & UPPER FLOOR
14:30 - 15:30
Meet the Expert 5: How valid is a biochemical diagnosis of chromaffin tumors?
HALL 1
ME5
Meet the Expert 5: How valid is a biochemical diagnosis of chromaffin tumors?
How valid is a biochemical diagnosis of chromaffin tumors?
F. Mantero
14:30 - 15:30
Meet the Expert 6: Beyond the bone – sporadic and hereditary hyperparathyroidism.
HALL 7
ME6
Meet the Expert 6: Beyond the bone – sporadic and hereditary hyperparathyroidism.
Beyond the bone – sporadic and hereditary hyperparathyroidism.
M. Toth
14:30 - 15:30
Meet the Expert 7: The sequelae of brain injury – is the pituitary involved?
HALL 3
ME7
Meet the Expert 7: The sequelae of brain injury – is the pituitary involved?
The sequelae of brain injury – is the pituitary involved?
F. Tanriverdi
14:30 - 15:30
Meet the Expert 8: MicroRNA
HALL 4/5
ME8
Meet the Expert 8: MicroRNA
microRNA
M. Scherr
15:30 - 17:00
Symposium 16 - Clinical: New insights in PCOS
HALL 1
Chairs: A. Milewicz (Poland) & S. Christin-Maitre (France)
S16.1
Symposium 16 - Clinical: New insights in PCOS
Definition of PCOS
B. Fauser
S16.2
Symposium 16 - Clinical: New insights in PCOS
New insights in Polycystic Ovary Syndrome
L. Ibáñez
S16.3
Symposium 16 - Clinical: New insights in PCOS
Vascular markers in PCOS
E. Diamanti-Kandarakis
S16.4
Symposium 16 - Clinical: New insights in PCOS
Treatment of PCOS
B. Bidzinska-Speichert
15:30 - 17:00
Symposium 17 - Basic: Thyroid Cell Biology
HALL 7
Chairs: J. Köhrle (Germany) & T.Visser (Netherlands)
S17.1
Symposium 17 - Basic: Thyroid Cell Biology
Basic mechanisms of thyroid development
S. Zannini
S17.2
Symposium 17 - Basic: Thyroid Cell Biology
Growth Factors Involved In Thyroid Cells Differentiation
P. Santisteban
S17.3
Symposium 17 - Basic: Thyroid Cell Biology
Molecular mechanisms of thyroid carcinogenesis: role of the CBX7 gene.Loss of the CBX7 gene.ll
A. Fusco
S17.4
Symposium 17 - Basic: Thyroid Cell Biology
Novel insights on the Na+/I- symporter (NIS): it mediates electroneutral active transport of the environmental pollutant perchlorate.
N. Carrasco
15:30 - 17:00
Oral Communication 4: Bone & Adrenal
HALL 4/5
Chairs: D. Schnabel (Germany) & A. Leal-Cerro (Spain)
OC4.1
Oral Communication 4: Bone & Adrenal
Inactivation of the Carney Complex (CNC) gene 1 (PKA regulatory subunit 1A, PRKAR1A) by interference RNA alters multiple signaling pathways and decreases apoptosis.
OC4.2
Oral Communication 4: Bone & Adrenal
Reduced fertility rates and high prevalence of testicular adrenal rest tumors (TART) in male patients with congenital adrenal hyperplasia
OC4.3
Oral Communication 4: Bone & Adrenal
BMP dependent modulation of adrenocortical growth and function
OC4.4
Oral Communication 4: Bone & Adrenal
Comparison of different test systems for the screening of inhibitors of CYP11B enzymes
OC4.5
Oral Communication 4: Bone & Adrenal
Comparison of 1-mg versus 8-mg dexamethasone suppression tests (DST) in patients with clinically inapparent adrenal adenoma.
OC4.6
Oral Communication 4: Bone & Adrenal
Isolation and characterization of cells coexpressing endothelial progenitors and parathyroid specific genes from human adult normal and tumoral parathyroids
OC4.7
Oral Communication 4: Bone & Adrenal
Molecular analysis of the calcium sensing receptor (CASR) gene in 40 patients clinically suspected to have familial hypocalciuric hypercalcemia (FHH)
OC4.8
Oral Communication 4: Bone & Adrenal
Incidental parathyroidectomy during thyroid surgery: outcome, follow-up and management of 231 patients treated between 1989 and 2007
OC4.9
Oral Communication 4: Bone & Adrenal
Teriparatide (TPTD) Treatment Followed by Either Zoledronic Acid (ZOL) 5mg Once Yearly or Strontium Ranelate (SR) 2g Daily: Preliminary Results from the ZOSTER-Study
15:30 - 17:00
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Sponsored by Merck Serono
HALL 3
Chairs: B. Allolio (Würzburg) & O. Hiort (Lübeck)
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Trekking the midline-development of the hypothalamus and the pituitary
Dr. Pogoda
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Sexual differentiation - What makes the difference?
P. Holterhus
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
A long way from its roots - the pancreatic beta cell
R. Scharfmann
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Walking the line - the thyroid gland development
H. Krude
17:15 - 18:00
Plenary Lecture 4
Berthold Lecture of the German Endocrine Society (DGE) Awards
HALL 1
Chairs: A. Grueters (Germany) & T. Gudermann (Germany)
PL4
Plenary Lecture 4
Genetics of Obesity
R. Leibel
18:00 - 19:30
General Assembly German Endocrine Society (DGE)
HALL 1
20:00 - 23:00
ECE Congress Party at Wasserwerk
Wasserwerk
Tuesday 06 May
26 sessions
08:30 - 10:00
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
HALL 1
Chairs: J. Christiansen (Denmark) & F. Kelestimur (Turkey)
S18.1
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Indirect evidence suggesting hormone abuse -- can it be proof of doping in sports?
A. Hackney
S18.2
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Doping with Androgens
W. Schänzer
S18.3
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Distinction between endogenous and exogenous GH
M. Bidlingmaier
S18.4
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Distinction between endogenous and exogenous erythropoietin (EPO)
J. Segura
08:30 - 10:00
Symposium 19 - Translational: Hormone receptors and adipose tissue
HALL 7
Chairs: H. Lehnert (Germany) & H. Bieberman (Germany)
S19.1
Symposium 19 - Translational: Hormone receptors and adipose tissue
The family of corticotropin-releasing hormone (CRH) peptides; important regulators of adipocyte function
D. Grammatopoulos
S19.2
Symposium 19 - Translational: Hormone receptors and adipose tissue
Corticosteroid receptors and adipocytes
J. Klein
S19.3
Symposium 19 - Translational: Hormone receptors and adipose tissue
Multi-layered receptor interactions in ghrelin-induced fat deposition
T. Wells
S19.4
Symposium 19 - Translational: Hormone receptors and adipose tissue
Adiponectin and its receptors in insulin resistance, diabetes, and metabolic syndrome, and obesity.
T. Kadowaki
08:30 - 10:00
Symposium 20: Translational Highlights
HALL 3
Chairs: J. Lado (Spain) & L. Persani (Italy)
S20.1
Symposium 20: Translational Highlights
sst2 gene transfer restores the somatostatin agonist sensitivity of human resistant pituitary adenomas, in vitro
J. Acunzo
S20.2
Symposium 20: Translational Highlights
SF-1 knockout mice as a model for hormone independent brain sexual differentiation
T. Spanic
S20.3
Symposium 20: Translational Highlights
Monoallelic mutations in DUOXA2 are associated with mild permanent hypothyroidism and goiter.
J. Moreno
S20.4
Symposium 20: Translational Highlights
Recent advances in stereological methods for studying microvessels in endocrine organs
R. Krasnoperov
S20.5
Symposium 20: Translational Highlights
V206M polymorphism of the SLC26A6 gene encoding a Cl--oxalate transporter in patients with primary hyperparathyroidism and kidney stones.
S. Corbetta
S20.6
Symposium 20: Translational Highlights
A functional AMH polymorphism is associated with follicle number and androgen levels in Polycystic Ovary Syndrome patients
J. Visser
10:05 - 10:50
Plenary Lecture 5
HALL 1
Chairs: P. Trainer (United Kingdom) & K. Raile (Germany)
PL5
Plenary Lecture 5
Too little and too much insulin: lessons from Newborns
A. Hattersley
10:50 - 11:15
Coffee Break and Exhibition
11:15 - 12:45
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
HALL 1
Chair: P. Beck-Peccoz (Italy)
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
CON
J. Nauman
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
PRO
U. Feldt-Rasmussen
11:15 - 12:25
Symposium 22 - Clinical: The metabolic effects of exercise
HALL 7
Chairs: L. Sidossis (Greece) & H. Randeva (United Kingdom)
S22.1
Symposium 22 - Clinical: The metabolic effects of exercise
Mechanisms for the delayed effects of exercise on lipid and lipoprotein metabolism
F. Magkos
S22.2
Symposium 22 - Clinical: The metabolic effects of exercise
Inflammation and physical activity
B. Pedersen
S22.3
Symposium 22 - Clinical: The metabolic effects of exercise
Why does physical exercise improve insulin sensitivity, the role of adipose tissue ?
J. Polak
S22.4
Symposium 22 - Clinical: The metabolic effects of exercise
Exercise and Bone
B. Noble
11:16 - 12:45
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
HALL 3
Chairs: A. Spada (Italy) & R. Pfaffle (Germany)
S23.1
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Pituitary Development and Congenital Hypopituitarism (CH)
M.T. Dattani
S23.2
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Atypical G-protein coupled receptor expression in pituitary tumors
J. Castano
S23.3
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Growth factors in pituitary tumour development
G. Stalla
S23.4
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Cell cycle control and proliferative diseases of the pituitary
M. Malumbres
11:17 - 12:45
Oral Communication 5: Reproduction
HALL 4/5
Chairs: A. Juul (Denmark) & S. Christin-Maitre (France)
OC5.1
Oral Communication 5: Reproduction
Female Fertility Defects and Puberty Delay in Mice Lacking Activin Receptor-Like Kinase 7
OC5.2
Oral Communication 5: Reproduction
The T222P mutation of the LGR8 gene is not causative for cryptorchidism
OC5.3
Oral Communication 5: Reproduction
Prokineticin-2 and prokineticin receptor-2 gene analysis in men with Kallmann Syndrome or normosmic hypogonadotropic hypogonadism
OC5.4
Oral Communication 5: Reproduction
Molecular and functional characterization of BMP15 variants associated with secondary amenorrhea and Premature Ovarian Failure (POF).
OC5.5
Oral Communication 5: Reproduction
Prevalence of Low Testosterone Levels in Primary Care in Germany: Cross-sectional Results from the DETECT Study
OC5.6
Oral Communication 5: Reproduction
Effects of pregnancy on GH/IGF-1 concentrations in acromegalic women.
OC5.7
Oral Communication 5: Reproduction
HEPATIC STEATOSIS IS NOT A FEATURE OF YOUNG LEAN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
OC5.8
Oral Communication 5: Reproduction
The effect of estrogens plus cyproterone acetate or orchiectomy on serum insulin like factor 3 (INSL3) levels in transsexual men
OC5.9
Oral Communication 5: Reproduction
Cognitive disabilities in the Novel Object Task of male mice carrying a supernumerary X chromosome (41, XX*Y)
13:00 - 14:30
Satellite Symposium: DuoCort AB - Optimized care for adrenal sufficiency
ROOM 7
13:00 - 14:£0
Satellite Symposium: Solvay Pharmaceuticals GmbH - Testosterone deficiency syndrome and cerdiovascular co-morbidities
HALL 1
13:00 - 14:30
Satellite Symposium: Worldwide Merck
HALL 3
13:00 - 14:30
Lunch
13:00 - 15:00
Poster session
14:30 - 15:30
Meet the Expert 9: An underestimated hormone: Prolactin
HALL 7
ME9
Meet the Expert 9: An underestimated hormone: Prolactin
Prolactin: An underestimated hormone
S. Güllü
14:30 - 15:30
Meet the Expert 10: How to prevent osteoporosis?
HALL 1
ME10
Meet the Expert 10: How to prevent osteoporosis?
How to prevent osteoporosis?
M. Bolanowski
14:30 - 15:30
Meet the Expert 11: More than a change of nomenclature disorders of sexual differentiation (DSD)
HALL 3
ME11
Meet the Expert 11: More than a change of nomenclature disorders of sexual differentiation (DSD)
More than a change of nomenclature: Disorders of Sex Development (DSD)
O. Hiort
14:30 - 15:30
Meet the Expert 12: Metabolomics and metabolics
HALL 4/5
ME12
Meet the Expert 12: Metabolomics and metabolics
Metabolomics and metabonomics
M. Oresic
15:30 - 17:00
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
HALL 1
Chairs: X. Bertagna (France) & A. Grossman (UK)
S24.1
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Nonfunctioning pituitary macroadenomas: treatment and follow-up
O. Dekkers
S24.2
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Medical therapy of Cushing's Disease
R. Pivonello
S24.3
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
The Sequealae of Cushing’s Disease
John Newell-Price
Sheffield, UK
S24.4
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Development of a disease-related QoL-questionnaire for Cushing’s disease
S.M. Webb
15:30 - 17:00
Symposium 25 - Basic: Stem cell and regeneration
HALL 7
Chairs: G. Schütz (Germany) & S. Bornstein (Germany)
S25.1
Symposium 25 - Basic: Stem cell and regeneration
Generation and patterning of patient-specific pluripotent stem cells
C. Lengerke
S25.2
Symposium 25 - Basic: Stem cell and regeneration
Stem cells in the gonads: Novel options for fertility preservation?
S. Schlatt
S25.3
Symposium 25 - Basic: Stem cell and regeneration
The cell biology of neural stem and progenitor cells
W. Huttner
S25.4
Symposium 25 - Basic: Stem cell and regeneration
Beta cell progenitor niche(s) and derivation of such cells from human ES cells
H. Semb
15:30 - 17:00
Symposium 26 - Clinical: New therapeutic options in diabetes
HALL 3
Chairs: J. Marek (Czech Republic) & U. Pagotto (Italy)
S26.1
Symposium 26 - Clinical: New therapeutic options in diabetes
Islet transplantation
P. Fiorina
S26.2
Symposium 26 - Clinical: New therapeutic options in diabetes
Regeneration of pancreatic beta cells
T. Otonkoski
S26.3
Symposium 26 - Clinical: New therapeutic options in diabetes
Emerging therapeutic approaches to preserve beta cell function in Type 1 DM
L. Chatenoud
S26.4
Symposium 26 - Clinical: New therapeutic options in diabetes
The one and only? Gene driving Type 2 DM
P. Froguel
15:30 - 17:00
Oral Communication 6: Metabolism & Cardiovascular
HALL 4/5
Chairs: F. Broglio (Italy) & M. Stummvoll (Germany)
OC6.1
Oral Communication 6: Metabolism & Cardiovascular
The signaling profile of recombinant human orexin-2 receptor (OX2R)
OC6.2
Oral Communication 6: Metabolism & Cardiovascular
Human adipocytes secrete new cardiodepressant factors: a direct link between obesity and heart failure
OC6.3
Oral Communication 6: Metabolism & Cardiovascular
Visfatin induces MMP-2/9 activation in human vascular endothelial cells via nuclear factor-кB
OC6.4
Oral Communication 6: Metabolism & Cardiovascular
Lipolysis in subcutaneous adipose tissue after intranasal administration of ACTH(4-10) is associated with an increased baroreceptor reflex sensitivity.
OC6.5
Oral Communication 6: Metabolism & Cardiovascular
Association of the SHBG gene promotor polymorphism with early markers of atherosclerosis in apparently healthy women
OC6.6
Oral Communication 6: Metabolism & Cardiovascular
Androgens increase blood pressure in orchiectomized male Wistar rats similar to high salt diet
OC6.7
Oral Communication 6: Metabolism & Cardiovascular
The mineralocorticoid receptor induces pro-inflammatory effects in white adipocytes and is essential for adipogenesis.
OC6.8
Oral Communication 6: Metabolism & Cardiovascular
Chronic prostaglandin excess results in adipose tissue wasting through increased substrate utilization
OC6.9
Oral Communication 6: Metabolism & Cardiovascular
The histone deacetylase inhibitor valproic (VPA) confers an estrogen-sensitive “Phenotype” to estrogen receptor-negative breast cancer cells MDA-MB 231.
17:15 - 18:00
Plenary Lecture 6
HALL 1
Chairs: A. Lewinski (Poland) & M. Alevizaki (Greece)
PL6
Plenary Lecture 6
Graves' Opthalmopathy - Problems solved and new questions to be answered
W. Wiersinga
18:00 - 18:15
Young Investigator Awards & Poster Awards
HALL 1
18:15 - 19:30
Annual General Meeting of the European Society of Endocrinology (ESE)
HALL 1
20:00 - 23:00
ECE Gala Dinner at Loewesaal
Loewesaal
Wednesday 07 May
12 sessions
08:30 - 10:00
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
HALL 1
Chairs: M. Erdogan (Turkey) & S. Mariotti (Italy)
S27.1
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Management of thyroid nodules: The European and the USA way
R. Paschke
S27.2
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Management of differentiated thyroid cancer.
F. Pacini
S27.3
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Therapeutic options and dilemmas in medullary thyroid carcinoma
B. Jarzab
S27.4
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Nodules and more
G. Brabant
08:30 - 10:00
Symposium 28 - Basic: GH: structure - function relationship
HALL 7
Chairs: P. Mollard (France) & C. Strasburger (Germany)
S28.1
Symposium 28 - Basic: GH: structure - function relationship
Plasticity in the Growth Hormone Axis
I. Robinson
S28.2
Symposium 28 - Basic: GH: structure - function relationship
The contribution of autocrine human growth hormone to neoplasia
P. Lobie
S28.3
Symposium 28 - Basic: GH: structure - function relationship
Multireceptor ligands in the treatment of pituitary adenomas
T. Brue
S28.4
Symposium 28 - Basic: GH: structure - function relationship
Trafficking and Function of GHR and the Role of GHBP
R.J. Ross
08:30 - 10:00
Symposium 29 - Translational: Too early-too late: The timing of puberty
HALL 3
Chairs: A. Huebner (Germany) & A. Juul (Denmark)
S29.1
Symposium 29 - Translational: Too early-too late: The timing of puberty
The Systems Biology of Puberty-Searching for Hypothalamic Gene Networks
S. Ojeda
S29.2
Symposium 29 - Translational: Too early-too late: The timing of puberty
Long acting GnRH analogues in the treatment of Central Precocious Puberty
J.C. Carel
S29.3
Symposium 29 - Translational: Too early-too late: The timing of puberty
Estrogen and kisspeptin regulation of GnRH neurons at puberty
A. Herbison
S29.4
Symposium 29 - Translational: Too early-too late: The timing of puberty
Human genetics of pubertal onset
N. Roux
08:30 - 10:00
Symposium 30: Clinical Highlights
HALL 4/5
Chairs: J. Salvador (Spain) & A. Colao (Italy)
S30.1
Symposium 30: Clinical Highlights
Reversible Kallmann syndrome associated with a novel homozygous mutation in the prokineticin receptor-2 gene
R. Asci
S30.2
Symposium 30: Clinical Highlights
Contrast-enhanced ultrasound of adrenal mass: Differentiation between benign and malignant lesions
M. Friedrich-Rust
S30.3
Symposium 30: Clinical Highlights
[123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma
S. Hahner
S30.4
Symposium 30: Clinical Highlights
Evaluation of endothelial function nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism
A. Ekmekci
S30.5
Symposium 30: Clinical Highlights
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline: dose and treatment duration effect
A-M. Colao
S30.6
Symposium 30: Clinical Highlights
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
D. Glintborg
10:05 - 10:50
Plenary Lecture 7
HALL 1
Chairs: J.L. Medina (Portugal) & E. Ghigo (Italy)
PL7
Plenary Lecture 7
Decreased sleep duration and quality: novel risk factors for obesity and diabetes
E. Cauter
10:50 - 11:15
Coffee Break & Exhibition
11:15 - 12:15
Meet the Professor 13: Endocrine management of gonadal tissue conservation
Hall 1
ME13
Meet the Professor 13: Endocrine management of gonadal tissue conservation
Endocrine management of gonadal tissue conservation
M Dolmans
11:15 - 12:15
Meet the Professor 14: Management of GI-NET
HALL 7
ME14
Meet the Professor 14: Management of GI-NET
Management of GI-NET
W.von Herder
11:15 - 12:15
Meet the Professor 15: Histopathology of thyroid tumors
HALL 3
ME15
Meet the Professor 15: Histopathology of thyroid tumors
Histopathology of Thyroid Tumors
M. Simoes
11:15 - 12:15
Meet the Professor 16: HRT in women - a never ending story?
HALL 4/5
ME16
Meet the Professor 16: HRT in women - a never ending story?
HRT in women – a never ending story?
N. Chabbert-Buffet
12:15 - 12:30
Plenary Lecture 8
HALL 1
Chairs: C. Dieguez (Spain) & S. Farooqi (UK)
PL8
Plenary Lecture 8
Central regulation of appetite and body weight – the role of peripheral signals
J. Brüning
12:50 - 13:00
Farewell and Invitations to Istanbul
HALL 1
N.Barzilai
Sun 04
17:15
PL2
Plenary Lecture 2
Why did Moses live to be 120?
N.Barzilai
E.Challet
Mon 05
09:30
S12.4
Symposium 12 - Translational: Addicted to Food?
Metabolic and reward cues affect the central clock in the brain
E.Challet
J. Achermann
Sun 04
15:50
S9.2
Symposium 9 - Clinical: New aspects of adrenal disease
The expanding spectrum of DAX1 and SF1 mutations
J. Achermann
J. Acunzo
Tue 06
08:30
S20.1
Symposium 20: Translational Highlights
sst2 gene transfer restores the somatostatin agonist sensitivity of human resistant pituitary adenomas, in vitro
J. Acunzo
W. Arlt
Sun 04
09:30
S1.4
Symposium 1 - Clinical: The trick is the combination
The combined Androgen and Estrogen replacement therapy in women
W. Arlt
R. Asci
Wed 07
08:30
S30.1
Symposium 30: Clinical Highlights
Reversible Kallmann syndrome associated with a novel homozygous mutation in the prokineticin receptor-2 gene
R. Asci
J. Auwerx
Mon 05
10:05
PL3
Plenary Lecture 3
A cofactor network that controls PGC-1alpha activity and energy homeostasis
J. Auwerx
J. Bach
Sun 04
08:30
S3.1
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Why is the incidence of autoimmune diseases increasing in the modern world?
J. Bach
L. Bartalena
Sun 04
08:30
S1.1
Symposium 1 - Clinical: The trick is the combination
Treatment of hyperthyroidism: block and replace versus titration
L. Bartalena
R. Batterham
Mon 05
08:50
S12.2
Symposium 12 - Translational: Addicted to Food?
Peptide YY: Cure for obesity?
R. Batterham
M. Bidlingmaier
Tue 06
09:10
S18.3
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Distinction between endogenous and exogenous GH
M. Bidlingmaier
B. Bidzinska-Speichert
Mon 05
16:30
S16.4
Symposium 16 - Clinical: New insights in PCOS
Treatment of PCOS
B. Bidzinska-Speichert
C. Birchmeier
Sun 04
11:35
S6.2
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
The zinc-finger factor Insm1 (IA-1) is essential for the development of endocrine cells of the pancreas, intestine and adrenal gland.
C. Birchmeier
W. Blum
Mon 05
11:15
S15.1
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
SHOX Deficiency: Does GH Treatment Do any Good?
W. Blum
A. Bojesen
Sun 04
11:55
S4.3
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Metabolic syndrome in Klinefelter syndrome (47,XXY)
A. Bojesen
M. Bolanowski
Tue 06
14:30
ME10
Meet the Expert 10: How to prevent osteoporosis?
How to prevent osteoporosis?
M. Bolanowski
G.B. Bolli
Sun 04
14:30
ME2
Meet the Expert 2: The necessity of Insulin analogues
Rational for using insulin analogues in the treatment of diabetes mellitus
G.B. Bolli
G. Brabant
Wed 07
09:30
S27.4
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Nodules and more
G. Brabant
J. Brosens
Sun 04
12:15
S5.4
Symposium 5 - Basic: Protein modifications / Proteomics
Progesterone Receptor Responses Modified by SUMO in the Endometrium
J. Brosens
T. Brue
Wed 07
09:10
S28.3
Symposium 28 - Basic: GH: structure - function relationship
Multireceptor ligands in the treatment of pituitary adenomas
T. Brue
J. Brüning
Wed 07
12:15
PL8
Plenary Lecture 8
Central regulation of appetite and body weight – the role of peripheral signals
J. Brüning
D. Calebiro
Germany
Mon 05
11:15
S14.1
Symposium 14: Basic Highlights
Direct vizualization of cyclic AMP levels in three dimensional cultures of thyroid follicles
D. Calebiro
Germany
J.C. Carel
Wed 07
08:50
S29.2
Symposium 29 - Translational: Too early-too late: The timing of puberty
Long acting GnRH analogues in the treatment of Central Precocious Puberty
J.C. Carel
N. Carrasco
Mon 05
16:30
S17.4
Symposium 17 - Basic: Thyroid Cell Biology
Novel insights on the Na+/I- symporter (NIS): it mediates electroneutral active transport of the environmental pollutant perchlorate.
N. Carrasco
J. Castano
Tue 06
11:35
S23.2
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Atypical G-protein coupled receptor expression in pituitary tumors
J. Castano
E. Cauter
Wed 07
10:05
PL7
Plenary Lecture 7
Decreased sleep duration and quality: novel risk factors for obesity and diabetes
E. Cauter
C. Cervino
Mon 05
12:30
S14.6
Symposium 14: Basic Highlights
Specific neuronal deletion of cannabinoid type 1 receptor (CB1) mice exhibits reduced fat mass and diet-induced obesity resistance
C. Cervino
N. Chabbert-Buffet
Wed 07
11:15
ME16
Meet the Professor 16: HRT in women - a never ending story?
HRT in women – a never ending story?
N. Chabbert-Buffet
L. Chatenoud
Tue 06
16:10
S26.3
Symposium 26 - Clinical: New therapeutic options in diabetes
Emerging therapeutic approaches to preserve beta cell function in Type 1 DM
L. Chatenoud
G. Chrousos
Sat 03
GH1
Opening Ceremony: Geoffrey Harris Prize Lecture
From Geoffrey Harris' hypothalamic principle to a unified theory of stress and stress system disorders
G. Chrousos
P. Clayton
Mon 05
12:15
S15.4
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
Consensus on GH Treatment in SGA
P. Clayton
A-M. Colao
Wed 07
09:30
S30.5
Symposium 30: Clinical Highlights
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline: dose and treatment duration effect
A-M. Colao
S. Corbetta
Tue 06
09:30
S20.5
Symposium 20: Translational Highlights
V206M polymorphism of the SLC26A6 gene encoding a Cl--oxalate transporter in patients with primary hyperparathyroidism and kidney stones.
S. Corbetta
D. Cota
Mon 05
09:10
S12.3
Symposium 12 - Translational: Addicted to Food?
Hypothalamic regulation of energy balance
D. Cota
J. Dahlgren
Mon 05
11:35
S15.2
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
GH therapy in Noonan Syndrome – facts and myths
J. Dahlgren
M.T. Dattani
Tue 06
11:15
S23.1
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Pituitary Development and Congenital Hypopituitarism (CH)
M.T. Dattani
O. Dekkers
Tue 06
15:30
S24.1
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Nonfunctioning pituitary macroadenomas: treatment and follow-up
O. Dekkers
P.J. Delhanty
Sun 04
16:10
S7.3
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and Bone
P.J. Delhanty
E. Diamanti-Kandarakis
Mon 05
16:10
S16.3
Symposium 16 - Clinical: New insights in PCOS
Vascular markers in PCOS
E. Diamanti-Kandarakis
P. Dijke
Sun 04
08:30
S2.1
Symposium 2 - Basic: The TGF-beta Superfamily
BMP to the Bone
P. Dijke
I. Dikic
Sun 04
11:55
S5.3
Symposium 5 - Basic: Protein modifications / Proteomics
Targeting ubiquitin networks
I. Dikic
M Dolmans
Wed 07
11:15
ME13
Meet the Professor 13: Endocrine management of gonadal tissue conservation
Endocrine management of gonadal tissue conservation
M Dolmans
G.S. Eisenbarth
Sun 04
09:10
S3.3
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Gene Environment Interactions in Type 1 Diabetes
G.S. Eisenbarth
A. Ekmekci
Wed 07
09:15
S30.4
Symposium 30: Clinical Highlights
Evaluation of endothelial function nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism
A. Ekmekci
B. Fauser
Mon 05
15:30
S16.1
Symposium 16 - Clinical: New insights in PCOS
Definition of PCOS
B. Fauser
U. Feldt-Rasmussen
Tue 06
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
PRO
U. Feldt-Rasmussen
P. Fiorina
Tue 06
15:30
S26.1
Symposium 26 - Clinical: New therapeutic options in diabetes
Islet transplantation
P. Fiorina
G. Forti
Mon 05
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
CON
G. Forti
P. Friedl
Sun 04
14:30
ME4
Meet the Expert 4: A living method: In vivo microscopy
Two-photon microscopy of cancer invasion and metastasis
P. Friedl
M. Friedrich-Rust
Wed 07
08:45
S30.2
Symposium 30: Clinical Highlights
Contrast-enhanced ultrasound of adrenal mass: Differentiation between benign and malignant lesions
M. Friedrich-Rust
P. Froguel
Tue 06
16:30
S26.4
Symposium 26 - Clinical: New therapeutic options in diabetes
The one and only? Gene driving Type 2 DM
P. Froguel
D. Führer
Sun 04
11:35
S5.2
Symposium 5 - Basic: Protein modifications / Proteomics
Applying proteomics to thyroid tumour diagnosis
D. Führer
A. Fusco
Mon 05
16:10
S17.3
Symposium 17 - Basic: Thyroid Cell Biology
Molecular mechanisms of thyroid carcinogenesis: role of the CBX7 gene.Loss of the CBX7 gene.ll
A. Fusco
V. Gawlik
Mon 05
12:00
S14.4
Symposium 14: Basic Highlights
Targeted disruption of Slc2a8 (GLUT8) reduces ATP levels and mitochondrial potential of spermatozoa
V. Gawlik
A-P. Gimenez-Roqueplo
Sun 04
16:30
S9.4
Symposium 9 - Clinical: New aspects of adrenal disease
Genetics of chromaffin tumours
A-P. Gimenez-Roqueplo
D. Glintborg
Wed 07
09:45
S30.6
Symposium 30: Clinical Highlights
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
D. Glintborg
D. Grammatopoulos
Tue 06
08:30
S19.1
Symposium 19 - Translational: Hormone receptors and adipose tissue
The family of corticotropin-releasing hormone (CRH) peptides; important regulators of adipocyte function
D. Grammatopoulos
R. Granata
Sun 04
15:50
S7.2
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and the endocrine pancreas
R. Granata
S. Güllü
Tue 06
14:30
ME9
Meet the Expert 9: An underestimated hormone: Prolactin
Prolactin: An underestimated hormone
S. Güllü
A. Hackney
Tue 06
08:30
S18.1
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Indirect evidence suggesting hormone abuse -- can it be proof of doping in sports?
A. Hackney
S. Hahner
Wed 07
09:00
S30.3
Symposium 30: Clinical Highlights
[123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma
S. Hahner
A. Hattersley
Tue 06
10:05
PL5
Plenary Lecture 5
Too little and too much insulin: lessons from Newborns
A. Hattersley
L. Hegedüs
Sun 04
09:30
S3.4
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Gene-environment interactions in thyroid autoimmunity.
L. Hegedüs
A. Herbison
Wed 07
09:10
S29.3
Symposium 29 - Translational: Too early-too late: The timing of puberty
Estrogen and kisspeptin regulation of GnRH neurons at puberty
A. Herbison
W.von Herder
Wed 07
11:15
ME14
Meet the Professor 14: Management of GI-NET
Management of GI-NET
W.von Herder
V. Heyningen
Mon 05
08:50
S11.2
Symposium 11 - Basic: Epigenetics in endocrinology
Mechanisms of selective gene expression in development
V. Heyningen
O. Hiort
Tue 06
14:30
ME11
Meet the Expert 11: More than a change of nomenclature disorders of sexual differentiation (DSD)
More than a change of nomenclature: Disorders of Sex Development (DSD)
O. Hiort
B. Hofmann
Mon 05
09:10
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Plant derived compunds with endocrine actions: Hops and Xanthohumols
B. Hofmann
A. Hokken-Koelega
Mon 05
11:55
S15.3
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
GH therapy in children with Prader Willi Syndrome (PWS)
A. Hokken-Koelega
P. Holterhus
Mon 05
15:50
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Sexual differentiation - What makes the difference?
P. Holterhus
B. Horsthemke
Mon 05
08:30
S11.1
Symposium 11 - Basic: Epigenetics in endocrinology
Epimutations in the human genome
B. Horsthemke
D. Hunter
Sun 04
08:50
S3.2
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Genome-wide association studies and hormone-dependent cancers
D. Hunter
K. Hussain
Sun 04
11:55
S6.3
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Hyperinsulinism in humans
K. Hussain
W. Huttner
Tue 06
16:10
S25.3
Symposium 25 - Basic: Stem cell and regeneration
The cell biology of neural stem and progenitor cells
W. Huttner
L. Ibáñez
Mon 05
15:50
S16.2
Symposium 16 - Clinical: New insights in PCOS
New insights in Polycystic Ovary Syndrome
L. Ibáñez
J. Janssen
Sun 04
08:50
S1.2
Symposium 1 - Clinical: The trick is the combination
The combination of GH/IGF-I makes the difference!
J. Janssen
H. Jarry
Mon 05
08:50
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Endocrine disruptors and reproductive hormones
H. Jarry
B. Jarzab
Wed 07
09:10
S27.3
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Therapeutic options and dilemmas in medullary thyroid carcinoma
B. Jarzab
N. Joergensen
Sun 04
11:15
S4.1
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Deterioration of male reproductive function in Europe. Geographical differences
N. Joergensen
G. Johansson
Sun 04
16:10
S9.3
Symposium 9 - Clinical: New aspects of adrenal disease
REPLACEMENT AND QoL IN PATIENTS WITH ADRENAL INSUFFICIENCY
G. Johansson
J. Jorgensen
Sun 04
09:10
S1.3
Symposium 1 - Clinical: The trick is the combination
Medical Treatment of Acromegaly: Dual Blockade with a Somatostatin Analog and Pegvisomant
J. Jorgensen
T. Kadowaki
Tue 06
09:30
S19.4
Symposium 19 - Translational: Hormone receptors and adipose tissue
Adiponectin and its receptors in insulin resistance, diabetes, and metabolic syndrome, and obesity.
T. Kadowaki
J. Klein
Tue 06
08:50
S19.2
Symposium 19 - Translational: Hormone receptors and adipose tissue
Corticosteroid receptors and adipocytes
J. Klein
J. Kohrle
Mon 05
08:30
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Endocrine disruptors and the thyroid
J. Kohrle
A. Kralli
Sun 04
16:30
S8.4
Symposium 8 - Basic: Nuclear Receptors
Estrogen-related receptors as regulators of energy homeostasis and adaptive metabolism
A. Kralli
R. Krasnoperov
Tue 06
09:15
S20.4
Symposium 20: Translational Highlights
Recent advances in stereological methods for studying microvessels in endocrine organs
R. Krasnoperov
H. Krude
Mon 05
16:30
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Walking the line - the thyroid gland development
H. Krude
R. Leibel
Mon 05
17:15
PL4
Plenary Lecture 4
Genetics of Obesity
R. Leibel
C. Lengerke
Tue 06
15:30
S25.1
Symposium 25 - Basic: Stem cell and regeneration
Generation and patterning of patient-specific pluripotent stem cells
C. Lengerke
R. Libé
Mon 05
11:45
S14.3
Symposium 14: Basic Highlights
Variants of the phosphodiesterase 11A (PDE11A4) gene and genetic predisposition to adrenocortical tumors (ACT)
R. Libé
P. Lobie
Wed 07
08:50
S28.2
Symposium 28 - Basic: GH: structure - function relationship
The contribution of autocrine human growth hormone to neoplasia
P. Lobie
B. Lunenfeld
Mon 05
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
PRO
B. Lunenfeld
F. Magkos
Tue 06
11:15
S22.1
Symposium 22 - Clinical: The metabolic effects of exercise
Mechanisms for the delayed effects of exercise on lipid and lipoprotein metabolism
F. Magkos
K. Main
Sun 04
11:35
S4.2
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Life style factors and chemical exposures impair male reproductive development and function in humans
K. Main
M. Malumbres
Tue 06
12:15
S23.4
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Cell cycle control and proliferative diseases of the pituitary
M. Malumbres
F. Mantero
Mon 05
14:30
ME5
Meet the Expert 5: How valid is a biochemical diagnosis of chromaffin tumors?
How valid is a biochemical diagnosis of chromaffin tumors?
F. Mantero
G. Mastorakos
Sun 04
14:30 - 15:30
ME3
Meet the Expert 3: Contraception in the new millennium
Contraception in the New Millennium
G. Mastorakos
P. Mehlen
Sun 04
09:30
S2.4
Symposium 2 - Basic: The TGF-beta Superfamily
The Dependence Receptor notion: When apoptosis regulates tumor progression and metastasis
P. Mehlen
M. Mendelssohn
Sun 04
10:05
PL1
Plenary Lecture 1
Estrogens and cardiovascular disease
M. Mendelssohn
D. Micic
Sun 04
14:30
ME1
Meet the Expert 1: The impact of abdominal obesity
The impact of abdominal obesity
D. Micic
J. Moreno
Tue 06
09:00
S20.3
Symposium 20: Translational Highlights
Monoallelic mutations in DUOXA2 are associated with mild permanent hypothyroidism and goiter.
J. Moreno
J. Nauman
Tue 06
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
CON
J. Nauman
John Newell-Price
Sheffield, UK
Tue 06
16:10
S24.3
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
The Sequealae of Cushing’s Disease
John Newell-Price
Sheffield, UK
T. Nilsson
Sun 04
11:15
S5.1
Symposium 5 - Basic: Protein modifications / Proteomics
Comparative proteomics as a tool in biology: The protein microscope
T. Nilsson
P. Njolstad
Sun 04
12:15
S6.4
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Carboxylester lipase (CEL) VNTR links exocrine dysfunction to endocrine dysfunction
P. Njolstad
B. Noble
Tue 06
12:15
S22.4
Symposium 22 - Clinical: The metabolic effects of exercise
Exercise and Bone
B. Noble
C. Ohlsson
Sat 03
EJE1
Opening Ceremony: European Journal of Endocrinology Prize Lecture
Sex Steroids in the Regulation of Bone Metabolism in Men
C. Ohlsson
S. Ojeda
Wed 07
08:30
S29.1
Symposium 29 - Translational: Too early-too late: The timing of puberty
The Systems Biology of Puberty-Searching for Hypothalamic Gene Networks
S. Ojeda
H. Ong
Sun 04
16:30
S7.4
Symposium 7 - Translational: The functions of peripheral GHrelin
Peptidyl growth hormone secretagogues in cardioprotection
H. Ong
M. Oresic
Tue 06
14:30
ME12
Meet the Expert 12: Metabolomics and metabolics
Metabolomics and metabonomics
M. Oresic
T. Otonkoski
Tue 06
15:50
S26.2
Symposium 26 - Clinical: New therapeutic options in diabetes
Regeneration of pancreatic beta cells
T. Otonkoski
F. Pacini
Wed 07
08:50
S27.2
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Management of differentiated thyroid cancer.
F. Pacini
R. Paschke
Wed 07
08:30
S27.1
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Management of thyroid nodules: The European and the USA way
R. Paschke
B. Pedersen
Tue 06
11:35
S22.2
Symposium 22 - Clinical: The metabolic effects of exercise
Inflammation and physical activity
B. Pedersen
N. Perakakis
Mon 05
12:15
S14.5
Symposium 14: Basic Highlights
KLF11 differentially regulates PDX1-induced activation of the human insulin promoter in rodent beta-cells and human non-beta-cells
N. Perakakis
A. Peters
Mon 05
08:30
S12.1
Symposium 12 - Translational: Addicted to Food?
The Selfish Brain: Competition for Energy Resources
A. Peters
R. Pivonello
Tue 06
15:50
S24.2
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Medical therapy of Cushing's Disease
R. Pivonello
Dr. Pogoda
Mon 05
15:30
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Trekking the midline-development of the hypothalamus and the pituitary
Dr. Pogoda
J. Polak
Tue 06
11:55
S22.3
Symposium 22 - Clinical: The metabolic effects of exercise
Why does physical exercise improve insulin sensitivity, the role of adipose tissue ?
J. Polak
I. Robinson
Wed 07
08:30
S28.1
Symposium 28 - Basic: GH: structure - function relationship
Plasticity in the Growth Hormone Axis
I. Robinson
C. Rochette-Egly
Sun 04
15:50
S8.2
Symposium 8 - Basic: Nuclear Receptors
Kinase signaling and retinoic acid nuclear receptors
C. Rochette-Egly
R.J. Ross
Wed 07
09:30
S28.4
Symposium 28 - Basic: GH: structure - function relationship
Trafficking and Function of GHR and the Role of GHBP
R.J. Ross
N. Roux
Wed 07
09:30
S29.4
Symposium 29 - Translational: Too early-too late: The timing of puberty
Human genetics of pubertal onset
N. Roux
E. Saez
Sun 04
15:30
S8.1
Symposium 8 - Basic: Nuclear Receptors
LXR
E. Saez
P. Santisteban
Mon 05
15:50
S17.2
Symposium 17 - Basic: Thyroid Cell Biology
Growth Factors Involved In Thyroid Cells Differentiation
P. Santisteban
M. Savage
Mon 05
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
CON
M. Savage
W. Schänzer
Tue 06
08:50
S18.2
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Doping with Androgens
W. Schänzer
R. Scharfmann
Mon 05
16:10
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
A long way from its roots - the pancreatic beta cell
R. Scharfmann
M. Scherr
Mon 05
14:30
ME8
Meet the Expert 8: MicroRNA
microRNA
M. Scherr
S. Schlatt
Tue 06
15:50
S25.2
Symposium 25 - Basic: Stem cell and regeneration
Stem cells in the gonads: Novel options for fertility preservation?
S. Schlatt
A. Schneyer
Sun 04
09:10
S2.3
Symposium 2 - Basic: The TGF-beta Superfamily
TGF-beta family ligands in glucose and fat homeostasis in adults
A. Schneyer
R. Schüle
Sun 04
16:10
S8.3
Symposium 8 - Basic: Nuclear Receptors
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
R. Schüle
J. Segura
Tue 06
09:30
S18.4
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Distinction between endogenous and exogenous erythropoietin (EPO)
J. Segura
H. Semb
Tue 06
16:30
S25.4
Symposium 25 - Basic: Stem cell and regeneration
Beta cell progenitor niche(s) and derivation of such cells from human ES cells
H. Semb
M. Simoes
Wed 07
11:15
ME15
Meet the Professor 15: Histopathology of thyroid tumors
Histopathology of Thyroid Tumors
M. Simoes
F. Spagnoli
Sun 04
11:15
S6.1
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Embryonic Pancreatic Development
F. Spagnoli
T. Spanic
Tue 06
08:45
S20.2
Symposium 20: Translational Highlights
SF-1 knockout mice as a model for hormone independent brain sexual differentiation
T. Spanic
G. Stalla
Tue 06
11:55
S23.3
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Growth factors in pituitary tumour development
G. Stalla
G. Stein
Sun 04
08:50
S2.2
Symposium 2 - Basic: The TGF-beta Superfamily
Integration of Skeletal Regulatory Signals in Nuclear Microenvironments
G. Stein
F. Tanriverdi
Mon 05
14:30
ME7
Meet the Expert 7: The sequelae of brain injury – is the pituitary involved?
The sequelae of brain injury – is the pituitary involved?
F. Tanriverdi
K. Temple
Mon 05
09:30
S11.4
Symposium 11 - Basic: Epigenetics in endocrinology
Imprinting in Human Disease – Lessons from the study of Transient Neonatal Diabetes
K. Temple
M. Tena-Sempere
Sun 04
15:30
S7.1
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and the Gonads
M. Tena-Sempere
M. Toth
Mon 05
14:30
ME6
Meet the Expert 6: Beyond the bone – sporadic and hereditary hyperparathyroidism.
Beyond the bone – sporadic and hereditary hyperparathyroidism.
M. Toth
J. Visser
Tue 06
09:45
S20.6
Symposium 20: Translational Highlights
A functional AMH polymorphism is associated with follicle number and androgen levels in Polycystic Ovary Syndrome patients
J. Visser
G. Vollmer
Mon 05
09:30
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Danger of combination? Interactions of low ose hormone therapy with phytoestrogens
G. Vollmer
S.M. Webb
Tue 06
16:30
S24.4
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Development of a disease-related QoL-questionnaire for Cushing’s disease
S.M. Webb
T. Wells
Tue 06
09:10
S19.3
Symposium 19 - Translational: Hormone receptors and adipose tissue
Multi-layered receptor interactions in ghrelin-induced fat deposition
T. Wells
W. Wiersinga
Tue 06
17:15
PL6
Plenary Lecture 6
Graves' Opthalmopathy - Problems solved and new questions to be answered
W. Wiersinga
J.M. Wit
Mon 05
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
PRO
J.M. Wit
K. Zacharowski
Sun 04
15:30
S9.1
Symposium 9 - Clinical: New aspects of adrenal disease
The role of toll-like receptors
K. Zacharowski
S. Zannini
Mon 05
15:30
S17.1
Symposium 17 - Basic: Thyroid Cell Biology
Basic mechanisms of thyroid development
S. Zannini
M. Zatelli
Mon 05
11:30
S14.2
Symposium 14: Basic Highlights
Dopamine receptor 2 activation reduces cells viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion
M. Zatelli
M. Zernicka-Goetz
Mon 05
09:10
S11.3
Symposium 11 - Basic: Epigenetics in endocrinology
Epigenetics in mammalian development
M. Zernicka-Goetz
M. Zitzmann
Sun 04
12:15
S4.4
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Metabolic Aspects of Testosterone Replacement
M. Zitzmann
Workshop
0
Oral
0
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
0
Symposium
0
No Session Type
0
0 result(s) found.
Please wait...
×
-
×
Abstracts from this event
Abstracts from other events
Session starts at:
Abstract time:
Event:
×